Заемный капитал Изменить Дата
AbbVie USD 62.48B 2.05B 2026-06
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 1.47B 5.38M 2026-09
Amgen USD 51.61B 250M 2026-09
Biogen USD 7.29B 1.7M 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Bristol-Myers Squibb USD 41.85B 244M 2026-09
Coherus Biosciences USD 51.08M 496K 2025-12
Eli Lilly USD 46.99B 872M 2026-09
Gilead Sciences USD 23.82B 17M 2026-09
Heron Therapeutics USD 140.64M 975K 2025-12
Ionis Pharmaceuticals USD 1.77B 140.62M 2026-09
J&J USD 35.8B 1.55B 2026-09
Malin Corporation EUR 0 0 2024-12
Merck USD 49.69B 1.39B 2026-09
Minerva Neurosciences USD 0 86.58M 2024-09
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Otsuka Holdings JPY 87.06B 77.6B 2026-09
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 60B 498M 2026-09
Regeneron Pharmaceuticals USD 1.99B 400K 2026-09
Vertex Pharmaceuticals USD 3.5B 3.39B 2026-09